NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of MK-7240 in Healthy Participants (MK-7240-009)

Active Not RecruitingPhase 1

Sponsor: Merck Sharp & Dohme LLC

Conditions: Healthy

Interventions: Tulisokibart Form 1, Tulisokibart Form 2

Countries: Australia

The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.

Eligibility overview

Sex: ALL

Age: 18 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria

The main inclusion criteria include but are not limited to the following:

* Has a body-mass index (BMI) between 18 and 32 kg/m\^2

Exclusion Criteria

The main exclusion criteria include but are not limited to the following:

* Has a history of more than 1 episode of herpes zoster infection or history of disseminated herpes zoster infection
* Has a history of or current active tuberculosis (TB) infection or history of latent TB that was not fully treated

Locations (2)

Brisbane, Queensland, Australia
Melbourne, Victoria, Australia